Explore › Condition › Opioid Use Disorder
Condition

Opioid Use Disorder

Also known as: Disorder, Opioid Use Opioid Use Disorder Opioid Use Disorders Opioid use disorder Opioid use disorder (disorder) opioid use disorder opioid use disorder; depression opioid use disorder; opioid overdose
18 findings 2 papers 13 related entities View in graph →

Related entities

interventions
pharmacotherapy for opioid use disorder2 Screening and Brief Intervention1 Positive screening for depression on PHQ-9 (Patient Health Questionnaire 9)1 Targeted outreach to women who inject opioids1 Taking multiple medications for chronic disease1
outcomes
Rate of speech2 No interest in food2 Leukocyte Nuclear Appendages, Hereditary Prevalence of1 Preference for burial1
populations
Pregnant Women2 Postmenopausal Women1
studys
PMC60600053 PMC96326903

Findings (50)

None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →

Papers (2)